Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06554_nanopub.RA7EeV6zyS9hrf64S2yyIC1LBeH9HPvXOpyd8IXp_TvWU#assertion>. }
Showing items 1 to 14 of
14
with 100 items per page.
- drugbank:DB06554 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06554 label "Gaboxadol [drugbank:DB06554]" assertion.
- drugbank:DB06554 seeAlso DB06554 assertion.
- drugbank:DB06554 description "Gaboxadol also known as 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol (THIP) is an experimental sleep aid drug developed by Lundbeck and Merck. In March, 2007, Merck and H. Lundbeck cancelled work on the drug, citing safety concerns and the failure of an efficacy trial. It acts on the GABA system, but possibly in a different way from benzodiazepines, nonbenzodiazepines and barbiturates - (Valium, Sodium Pentothal, Ambien etc.). Lundbeck states that gaboxadol also increases deep sleep (stage 4). It is, however, not reinforcing like benzodiazepines are. [Wikipedia]" assertion.
- drugbank:DB06554 identifier "drugbank:DB06554" assertion.
- drugbank:DB06554 title "Gaboxadol" assertion.
- drugbank:DB06554 drugbank_vocabulary:x-cas cas:64603-91-4 assertion.
- drugbank:DB06554 drugbank_vocabulary:drugbank-id "DB06554" assertion.
- drugbank:DB06554 bio2rdf_vocabulary:x-identifiers.org DB06554 assertion.
- drugbank:DB06554 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06554" assertion.
- drugbank:DB06554 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06554 bio2rdf_vocabulary:identifier "DB06554" assertion.
- drugbank:DB06554 drugbank_vocabulary:x-wikipedia wikipedia:Gaboxadol assertion.
- drugbank:DB06554 drugbank_vocabulary:x-kegg kegg:D04282 assertion.